Cas:217195-91-0 ethyl 2-hydroxy-2-(trifluoromethyl)-4-methylpent-4-enoate 97 manufacturer & supplier

We serve Chemical Name:ethyl 2-hydroxy-2-(trifluoromethyl)-4-methylpent-4-enoate 97 CAS:217195-91-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

ethyl 2-hydroxy-2-(trifluoromethyl)-4-methylpent-4-enoate 97

Chemical Name:ethyl 2-hydroxy-2-(trifluoromethyl)-4-methylpent-4-enoate 97
CAS.NO:217195-91-0
Synonyms:Ethyl 2-hydroxy-4-methyl-2-(trifluoromethyl)pent-4-enoate;4-Pentenoic acid, 2-hydroxy-4-methyl-2-(trifluoromethyl)-, ethyl ester;2-hydroxy-4-methyl-2-trifluoromethylpent-4-enoic acid ethyl ester;Ethyl 2-hydroxy-4-methyl-2-(trifluoromethyl)-4-pentenoate
Molecular Formula:C9H13F3O3
Molecular Weight:226.193
HS Code:2918199090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:243.1±35.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.411
PSA:46.53000
Exact Mass:226.081680
LogP:3.32

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Ethyl 2-hydroxy-4-methyl-2-(trifluoromethyl)pent-4-enoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ethyl 2-hydroxy-4-methyl-2-(trifluoromethyl)-4-pentenoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Ethyl 2-hydroxy-4-methyl-2-(trifluoromethyl)pent-4-enoate Use and application,4-Pentenoic acid, 2-hydroxy-4-methyl-2-(trifluoromethyl)-, ethyl ester technical grade,usp/ep/jp grade.


Related News: Earlier this month, the drugmaker lifted a voluntary EU marketing hold on Zynteglo for beta thalassemia, after a patient death in one of the drugmaker’s other products, LentiGlobin, halted clinical studies. (diethoxyphosphoryl)methyl (R)-2-(4-((3,5-dichloropyridin-2-yl)oxy)phenoxy)propanoate manufacturers The outlay will be used to grow Takeda’s portfolio of treatments and boost capacity to manufacture additional products for the rare disease community, Stephen Hatke, Takeda’s Thousand Oaks site head, said in a YouTube video about the expansion. The company didn’t name the specific products it plans to make there. 1,6-dihydro-6-oxo-2-phenyl-N-(2-pyridyl)-5-pyrimidinecarboxamide suppliers J&J’s shot generates roughly 8 GBS cases per million vaccinated people, far higher than just a single case reported per million among mRNA recipients, CDC reported. N-(4-Methoxyphenyl)-2-methyl-3-oxo-3,4-dihydro-2H-1,2-benzothiazi ne-4-carboxamide 1,1-dioxide vendor & factory.